Stay updated with breaking news from Smoldering Multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Telo Genomics Corp. , , a biotech company pioneering the most comprehensive A.I. based genomic medical testing, is excited to announce that the College of American Pathologists Accreditation Office...
Telo Genomics Corp. announces today that the American Society of Hematology has accepted the results of TeloView-SMM technical repeatability validation for presentation at their annual meeting in...
Telo Genomics Corp. is pleased to announce that it has passed all requirements and received its Certificate of Accreditation of ISO 15189. Importantly, the rigorous ISO 15189 is the...
/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...
Telo Genomics Corp. today announced the launch of its TeloViewSMM to clinicians in the United States. Combining molecular biology and artificial intelligence, the diagnostic platform performs...